At the news
? NEUTRALIMPACT 3/10 8-K filed Apr 17, 2026 at 16:17 ET
IMAX Corporation appointed Chief Legal Officer Robert D. Lister as interim principal executive officer while CEO Richard Gelfond is on temporary medical leave. Gelfond is expected to resume his role on May 1, 2026. Lister will not receive additional compensation for this temporary assignment.
- CEO Richard Gelfond is on temporary medical leave, previously announced on March 30, 2026
- Robert D. Lister, Chief Legal Officer and Senior Executive Vice President, appointed interim principal executive officer effective April 16, 2026
- Lister will serve in this role until May 1, 2026, when Gelfond is expected to resume duties
- No additional compensation will be paid to Lister for the interim role
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access